PredicineCARE Urine Test Advances in FDA Review for Bladder Cancer
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A urine test for bladder cancer is advancing in the review process with the FDA. The test, known as PredicineCARE, is being considered for approval. The review is ongoing, with the outcome not yet determined.